Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Capturing farm diversity with hypothesis-based typologies: An innovative methodological framework for farming system typology development.

Alvarez S, Timler CJ, Michalscheck M, Paas W, Descheemaeker K, Tittonell P, Andersson JA, Groot JCJ.

PLoS One. 2018 May 15;13(5):e0194757. doi: 10.1371/journal.pone.0194757. eCollection 2018.

2.

Combating Multidrug-Resistant Pathogens with Host-Directed Nonantibiotic Therapeutics.

Andersson JA, Sha J, Kirtley ML, Reyes E, Fitts EC, Dann SM, Chopra AK.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e01943-17. doi: 10.1128/AAC.01943-17. Print 2018 Jan.

3.

Identification of New Virulence Factors and Vaccine Candidates for Yersinia pestis.

Andersson JA, Sha J, Erova TE, Fitts EC, Ponnusamy D, Kozlova EV, Kirtley ML, Chopra AK.

Front Cell Infect Microbiol. 2017 Oct 17;7:448. doi: 10.3389/fcimb.2017.00448. eCollection 2017.

4.

A Bivalent Anthrax-Plague Vaccine That Can Protect against Two Tier-1 Bioterror Pathogens, Bacillus anthracis and Yersinia pestis.

Tao P, Mahalingam M, Zhu J, Moayeri M, Kirtley ML, Fitts EC, Andersson JA, Lawrence WS, Leppla SH, Chopra AK, Rao VB.

Front Immunol. 2017 Jun 26;8:687. doi: 10.3389/fimmu.2017.00687. eCollection 2017.

5.

New Insights into Autoinducer-2 Signaling as a Virulence Regulator in a Mouse Model of Pneumonic Plague.

Fitts EC, Andersson JA, Kirtley ML, Sha J, Erova TE, Chauhan S, Motin VL, Chopra AK.

mSphere. 2016 Dec 14;1(6). pii: e00342-16. eCollection 2016 Nov-Dec.

6.

Protective Immunity Elicited by Oral Immunization of Mice with Salmonella enterica Serovar Typhimurium Braun Lipoprotein (Lpp) and Acetyltransferase (MsbB) Mutants.

Erova TE, Kirtley ML, Fitts EC, Ponnusamy D, Baze WB, Andersson JA, Cong Y, Tiner BL, Sha J, Chopra AK.

Front Cell Infect Microbiol. 2016 Nov 10;6:148. eCollection 2016.

7.

Immunisation of two rodent species with new live-attenuated mutants of Yersinia pestis CO92 induces protective long-term humoral- and cell-mediated immunity against pneumonic plague.

Tiner BL, Sha J, Cong Y, Kirtley ML, Andersson JA, Chopra AK.

NPJ Vaccines. 2016 Oct 13;1:16020. doi: 10.1038/npjvaccines.2016.20. eCollection 2016.

8.

A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates.

Sha J, Kirtley ML, Klages C, Erova TE, Telepnev M, Ponnusamy D, Fitts EC, Baze WB, Sivasubramani SK, Lawrence WS, Patrikeev I, Peel JE, Andersson JA, Kozlova EV, Tiner BL, Peterson JW, McWilliams D, Patel S, Rothe E, Motin VL, Chopra AK.

Clin Vaccine Immunol. 2016 Jul 5;23(7):586-600. doi: 10.1128/CVI.00150-16. Print 2016 Jul.

9.

New Role for FDA-Approved Drugs in Combating Antibiotic-Resistant Bacteria.

Andersson JA, Fitts EC, Kirtley ML, Ponnusamy D, Peniche AG, Dann SM, Motin VL, Chauhan S, Rosenzweig JA, Sha J, Chopra AK.

Antimicrob Agents Chemother. 2016 May 23;60(6):3717-29. doi: 10.1128/AAC.00326-16. Print 2016 Jun.

10.

Cross-talk among flesh-eating Aeromonas hydrophila strains in mixed infection leading to necrotizing fasciitis.

Ponnusamy D, Kozlova EV, Sha J, Erova TE, Azar SR, Fitts EC, Kirtley ML, Tiner BL, Andersson JA, Grim CJ, Isom RP, Hasan NA, Colwell RR, Chopra AK.

Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):722-7. doi: 10.1073/pnas.1523817113. Epub 2016 Jan 5.

11.

Beyond conservation agriculture.

Giller KE, Andersson JA, Corbeels M, Kirkegaard J, Mortensen D, Erenstein O, Vanlauwe B.

Front Plant Sci. 2015 Oct 28;6:870. doi: 10.3389/fpls.2015.00870. eCollection 2015. Review.

12.

High-throughput, signature-tagged mutagenic approach to identify novel virulence factors of Yersinia pestis CO92 in a mouse model of infection.

Ponnusamy D, Fitts EC, Sha J, Erova TE, Kozlova EV, Kirtley ML, Tiner BL, Andersson JA, Chopra AK.

Infect Immun. 2015 May;83(5):2065-81. doi: 10.1128/IAI.02913-14. Epub 2015 Mar 9.

13.

Combinational deletion of three membrane protein-encoding genes highly attenuates yersinia pestis while retaining immunogenicity in a mouse model of pneumonic plague.

Tiner BL, Sha J, Kirtley ML, Erova TE, Popov VL, Baze WB, van Lier CJ, Ponnusamy D, Andersson JA, Motin VL, Chauhan S, Chopra AK.

Infect Immun. 2015 Apr;83(4):1318-38. doi: 10.1128/IAI.02778-14. Epub 2015 Jan 20.

14.
15.

Efficient four fragment cloning for the construction of vectors for targeted gene replacement in filamentous fungi.

Frandsen RJ, Andersson JA, Kristensen MB, Giese H.

BMC Mol Biol. 2008 Aug 1;9:70. doi: 10.1186/1471-2199-9-70.

16.

The paranasal sinuses as reservoirs for nitric oxide.

Andersson JA, Cervin A, Lindberg S, Uddman R, Cardell LO.

Acta Otolaryngol. 2002 Dec;122(8):861-5.

PMID:
12542206
17.

Heme oxygenase and nitric oxide synthase in human middle ear epithelium indicates local carbon monoxide and nitric oxide production.

Andersson JA, Uddman R, Tajti J, Cardell LO.

Acta Otolaryngol. 2002 Sep;122(6):634-7.

PMID:
12403126
18.
19.

A decrease in maxillary sinus pressure, as seen in upper airway allergy or infection, results in an increase in upper airway nitric oxide levels.

Andersson JA, Cervin A, Lindberg S, Uddman R, Cardell LO.

Acta Otolaryngol. 2002 Jul;122(5):520-3.

PMID:
12206262
20.
22.

Pituitary adenylate cyclase-activating peptide 38 a potent endogenously produced dilator of human airways.

Kinhult J, Andersson JA, Uddman R, Stjärne P, Cardell LO.

Eur Respir J. 2000 Feb;15(2):243-7.

23.

Carbon monoxide is endogenously produced in the human nose and paranasal sinuses.

Andersson JA, Uddman R, Cardell LO.

J Allergy Clin Immunol. 2000 Feb;105(2 Pt 1):269-73.

PMID:
10669846

Supplemental Content

Loading ...
Support Center